Biogen's Tecfidera Safe Following IPR Decision – For Now

 
• By Jessica Merrill
  
SC2002_Baseball_291777503_1200.jpg
Biogen avoided a generic Tecfidera challenge • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Business